Risk-Specific Optimal Cancer Screening Schedules: An Application to Breast Cancer Early Detection

Statistics in Biosciences

Volumn 3, Issue 2, 2011, Pages 169-186

  Ahern, Charlotte Hsieh ^a   Cheng, Yi ^b   Shen, Yu ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SOUTH BEND   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer screening; Non stable disease model; Optimal exam times; Screening sensitivity; Sojourn time; Utility function

Indexed keywords

AGE; ARTICLE; BREAST CANCER; CANCER MODEL; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CLINICAL EXAMINATION; COST; DECISION THEORY; EARLY DIAGNOSIS; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; QUANTITATIVE STUDY;

EID: 80955152007     PISSN: 18671764     EISSN: 18671772     Source Type: Journal    
DOI: 10.1007/s12561-011-9032-7     Document Type: Article

References (20)

1. American Cancer Society (2006) Detailed guide: breast cancer. Can breast cancer be found early? http://www. cancer. org/. Accessed Dec 2008.
2. American Society (2010) Breast cancer facts and figures 2009-2010. http://www. cancer. org/Research/CancerFactsFigures/BreastCancerFactsFigures/. Accessed Aug 2010.
3. Boer R, Plevritis S, Clarke L (2004) Diversity of model approaches for breast cancer screening: a review of model assumptions by the Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups. Stat Methods Med Res 13: 525-538.
4. Day NE, Walter SD (1984) Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 40: 1-14.
5. Knudsen AB, McMahon PM, Gazelle GS (2007) Use of modeling to evaluate the cost-effectiveness of cancer screening programs. J Clin Oncol 25: 203-208.
6. Lee SJ, Zelen M (1998) Scheduling periodic examinations for the early detection of disease: applications to breast cancer. J Am Stat Assoc 93: 1271-1281.
7. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, deKonig HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ (2009) Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 151: 738-747.
8. Mandelblatt JS, Schechter CB, Yabroff KR, Lawrence W, Dignam J, Muennig P, Chavez Y, Cullen J, Fahs M (2004) Benefits and costs of interventions to improve breast cancer outcomes in African American women. J Clin Oncol 22: 2554-2566.
9. National Cancer Institute (2007) Breast cancer: screening and testing. http://www. cancer. gov/cancertopics/screening/breast/. Accessed Dec 2008.
10. NHS Cancer Screening Programmes (2008) NHS breast screening programme. http://cancerscreening. org. uk/breastscreen/. Accessed Dec 2008.
11. Parmigiani G (1993) On optimal screening ages. J Am Stat Assoc 88: 622-628.
12. Rosen PR, Groshen S, Saigo PE, Kinne DW, Hellman S (1989) A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 7: 355-366.
13. Rudin W (1976) Principles of mathematical analysis, 3rd edn. McGraw-Hill Science, New York.
14. Shen Y, Parmigiani G (2005) A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examination. Cancer Epidemiol Biomarkers Prev 14: 529-532.
15. Shen Y, Zelen M (2001) Screening sensitivity and sojourn time from breast cancer early detection trials: mammograms and physical examinations. J Clin Oncol 9: 3490-3499.
16. Shen Y, Zelen M (1999) Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding. Biometrika 86: 503-515.
17. Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG (2006) Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst 98: 774-782.
18. Tsodikov AD, Yakovlev AY (1991) On the optimal policies of breast cancer screening. Math Biosci 107: 21-45.
19. US Preventive Services Task Force (2009) Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 151: 716-726.
20. Zelen M (1993) Optimal scheduling of examinations for the early detection of disease. Biometrika 80: 279-293.